Arun, N., A. Dev, and V. K. Singh. “A Study on the Efficacy of 24 Weeks of Sofosbuvir, Daclatasvir With Ribaravin in the Treatment of Chronic Hepatitis C Patients With Cirrhosis, Genotype 1 and 3.”. Asian Journal of Medical Research, Vol. 7, no. 4, Jan. 2019, pp. ME25-ME28, https://aijournals.com/index.php/ajmr/article/view/434.